Brokerages Set American Healthcare REIT, Inc. (NYSE:AHR) PT at $25.13

Shares of American Healthcare REIT, Inc. (NYSE:AHR) have earned a consensus recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $25.13.

AHR has been the subject of several research reports. Royal Bank of Canada lifted their target price on American Healthcare REIT from $28.00 to $30.00 and gave the company an “outperform” rating in a research report on Monday, November 18th. Truist Financial lifted their target price on American Healthcare REIT from $27.00 to $29.00 and gave the company a “buy” rating in a research report on Friday, November 15th. Colliers Securities raised American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research report on Sunday, October 13th. Morgan Stanley lifted their target price on American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a research report on Thursday, August 22nd. Finally, Bank of America lifted their price objective on American Healthcare REIT from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Tuesday, September 24th.

American Healthcare REIT Stock Down 1.2 %

Shares of NYSE:AHR opened at $27.86 on Wednesday. The business has a 50-day moving average price of $26.63 and a 200 day moving average price of $21.17. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $4.26 billion and a price-to-earnings ratio of -58.03. American Healthcare REIT has a 12-month low of $12.63 and a 12-month high of $29.99.

American Healthcare REIT (NYSE:AHR) last released its earnings results on Tuesday, November 12th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.35). The firm had revenue of $523.81 million during the quarter, compared to analyst estimates of $474.26 million. American Healthcare REIT had a negative net margin of 1.84% and a negative return on equity of 1.87%. The firm’s quarterly revenue was up 12.8% on a year-over-year basis. Sell-side analysts expect that American Healthcare REIT will post 1.42 EPS for the current year.

Institutional Investors Weigh In On American Healthcare REIT

Institutional investors have recently added to or reduced their stakes in the business. Charles Schwab Investment Management Inc. lifted its stake in American Healthcare REIT by 118.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,907,986 shares of the company’s stock worth $49,798,000 after purchasing an additional 1,034,365 shares during the last quarter. Manning & Napier Advisors LLC purchased a new stake in American Healthcare REIT during the second quarter worth approximately $3,317,000. Foundations Investment Advisors LLC purchased a new stake in American Healthcare REIT during the third quarter worth approximately $568,000. Swiss National Bank lifted its stake in American Healthcare REIT by 126.6% during the third quarter. Swiss National Bank now owns 291,400 shares of the company’s stock worth $7,606,000 after purchasing an additional 162,800 shares during the last quarter. Finally, Hilton Capital Management LLC purchased a new stake in American Healthcare REIT during the third quarter worth approximately $4,777,000. Hedge funds and other institutional investors own 16.68% of the company’s stock.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.